Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06254157 · ClinicalTrials.gov registry record

Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials

A clinical trial, sponsored by Power Life Sciences.

Not yet
Registry status
500
Enrollment target

NCT06254157 is a clinical trial that has not yet begun recruiting, run by Power Life Sciences. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06254157 has not yet begun recruiting, sponsored by Power Life Sciences.

NOT YET RECRUITING
Registry status
500 participants
Enrollment target

Study Summary

Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences of individuals with generalized anxiety disorder. The goal is to identify the factors that hinder a patient's enrollment or completion of a trial. Additionally, the research will examine the data from various demographic perspectives to identify recurring patterns that could offer valuable insights for future generalized anxiety disorder patients.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2025-03
Est. Completion 2027-03

Sponsor

Power Life Sciences

62 total trials

What the Registry Record Tells You About NCT06254157

The ClinicalTrials.gov registry entry for NCT06254157 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Power Life Sciences, which has 62 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT06254157 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06254157 about?

NCT06254157 is a clinical study titled "Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials". Typically, certain demographic groups tend to participate more in medical research. However, there is insufficient research explaining the trial characteristics that influence the involvement of these specific demographics. This study aims to collect extensive data on the clinical trial experiences...

What is the current status of trial NCT06254157?

This trial is currently not yet recruiting. The enrollment target is 500 participants. The study started on 2025-03. Estimated completion is 2027-03.

Who is sponsoring clinical trial NCT06254157?

This trial is sponsored by Power Life Sciences, which has 62 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.